Home / Resource Library / ORELABRUTINIB, FLUDARABINE, CYCLOPHOSPHAMIDE, AND OBINUTUZUMAB (OFCG) FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTICENTER, INVESTIGATOR-INITIATED STUDY (CWCLL-001 STUDY)
ORELABRUTINIB, FLUDARABINE, CYCLOPHOSPHAMIDE, AND OBINUTUZUMAB (OFCG) FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTICENTER, INVESTIGATOR-INITIATED STUDY (CWCLL-001 STUDY)